Reference-pricing spillovers

U.S. adoption of MFN/reference pricing reshapes drug launch timing and prices in other countries and prompts strategic responses by firms and governments. — Determines cross-national access to medicines, pressures smaller markets, and creates trade and regulatory tensions requiring international coordination.